Optasia Medical to Demonstrate Innovative X-Ray Analysis Capabilities at Leading Industry Events

Optasia Medical introduces powerful new clinical workflow tools for the interpretation of x-rays for osteoporosis and arthritis

Sudbury, MA, October 12, 2010 --(PR.com)-- Optasia Medical Inc, a leading image analysis software applications provider today announced that it will attend several key industry conferences throughout the fourth quarter of 2010. Key Optasia Medical experts will demonstrate Optasia’s expanded suite of software products including SpineAnalyzerTM and RApidScoreTM. These software tools facilitate the rapid and efficient analysis and reporting of x-rays acquired for the diagnosis and treatment of osteoporosis and rheumatoid arthritis. The upcoming events include:

October 15-19, 2010: American Society of Bone Mineral Research (ASBMR) 2010 Annual Meeting, Toronto, Canada

November 7-11, 2010: 74th American College of Rheumatology (ACR/ARHP) Annual Scientific Meeting, Atlanta, GA

November 28-December 3, 2010: 96th Radiolical Society of North America (RSNA) Scientific Meeting, Chicago, IL

About Optasia Medical
Optasia makes software that facilitates the reading of x-rays for the management of musculoskeletal diseases. Our products are used in clinical trials and by physicians to identify and monitor patients who will benefit from treatment. With Optasia Medical's automated workflow tools, x-rays can be evaluated more rapidly, more accurately and more reproducibly. Optasia Medical’s current offerings include SpineAnalyzer™, a PACS/DICOM workstation for the assessment and documentation of vertebral fractures in osteoporosis, KneeAnalyzer™, which quantifies joint space narrowing in Osteoarthritis, and RApidScore™, for the rapid documentation of disease progression in hand and foot x-rays of patients suffering from rheumatoid arthritis. For more information about the software applications that Optasia can provide visit: www.optasiamedical.com.

###
Contact
Optasia Medical, Ltd.
Peter Steiger
+1 (508) 405-4392
www.optasiamedical.com
Alan Brett, Chief Technology Officer
Tel:+44 (0)161 491 7860
Email: alan.brett@optasiamedical.com
ContactContact
Categories